By Research Area
Hot products 
-
Mouse Anti-ADGRE2 Recombinant Antibody (V2-261270) (CBMAB-C0813-LY)
-
Mouse Anti-AHCYL1 Recombinant Antibody (V2-180270) (CBMAB-A1703-YC)
-
Mouse Anti-CA9 Recombinant Antibody (CBXC-2079) (CBMAB-C0131-CQ)
-
Mouse Anti-ATG5 Recombinant Antibody (9H197) (CBMAB-A3945-YC)
-
Mouse Anti-APOA1 Monoclonal Antibody (CBFYR0637) (CBMAB-R0637-FY)
-
Mouse Anti-AMOT Recombinant Antibody (CBYC-A564) (CBMAB-A2552-YC)
-
Mouse Anti-BIRC5 Recombinant Antibody (6E4) (CBMAB-CP2646-LY)
-
Mouse Anti-CD83 Recombinant Antibody (HB15) (CBMAB-C1765-CQ)
-
Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)
-
Mouse Anti-ADIPOR2 Recombinant Antibody (V2-179983) (CBMAB-A1369-YC)
-
Mouse Anti-ACTB Recombinant Antibody (V2-179553) (CBMAB-A0870-YC)
-
Mouse Anti-ACTG1 Recombinant Antibody (V2-179597) (CBMAB-A0916-YC)
-
Rabbit Anti-ABL1 (Phosphorylated Y245) Recombinant Antibody (V2-505716) (PTM-CBMAB-0465LY)
-
Mouse Anti-B2M Recombinant Antibody (CBYY-0050) (CBMAB-0050-YY)
-
Mouse Anti-BZLF1 Recombinant Antibody (BZ.1) (CBMAB-AP705LY)
-
Rabbit Anti-DLK1 Recombinant Antibody (9D8) (CBMAB-D1061-YC)
-
Rabbit Anti-Acetyl-Histone H3 (Lys36) Recombinant Antibody (V2-623395) (CBMAB-CP0994-LY)
-
Rabbit Anti-ALDOA Recombinant Antibody (D73H4) (CBMAB-A2314-YC)
Explore High-Affinity Antibody by Tumor Type
The paradigm of modern oncology has shifted definitively from broad-spectrum cytotoxic approaches to precision medicine, driven by a granular understanding of tumor heterogeneity. Cancer is not a monolithic disease, but a constellation of distinct pathologies defined by their tissue of origin, driver mutations, and the unique architecture of the Tumor Microenvironment (TME). To facilitate targeted therapeutic discovery, researchers must navigate specific molecular signatures inherent to each histological subtype.
In the realm of hormone-driven malignancies, particularly Breast and Prostate cancers, current research focuses heavily on resistance mechanisms in hormone receptor signaling and the interrogation of DNA damage response pathways (e.g., BRCA1/2). Conversely, high-mortality solid tumors such as Lung, Colorectal, and Pancreatic carcinomas present unique challenges related to metabolic reprogramming and dense desmoplastic stroma that impedes drug delivery. Unlocking the signaling cascades of KRAS, EGFR, and p53 in these tissues remains a priority for the development of next-generation inhibitors. Distinct immunological profiles are observed in Melanoma, which has served as the proving ground for checkpoint blockade immunotherapies, and Glioma, where the blood-brain barrier and a highly immunosuppressive myeloid landscape complicate treatment. Furthermore, the study of Ovarian cancer continues to highlight the importance of early detection biomarkers, while Hematologic malignancies—spanning leukemias, lymphomas, and myelomas—drive innovation in CAR-T cell therapies and the understanding of hematopoietic stem cell niches.
Empowering Discovery with Comprehensive Research
At Creative Biolabs, we recognize that the reproducibility of translational research hinges on both the fidelity of your reagents and the depth of your scientific resources. To support the rigorous demands of cancer biology, we offer a holistic platform that extends beyond our comprehensive portfolio of high-affinity antibodies. Whether characterizing surface antigens in flow cytometry, mapping spatial protein expression via immunohistochemistry (IHC), or quantifying signaling phosphorylation in Western blot, our tools are complemented by a wealth of technical and educational support.
We assist your investigation into complex oncogenic mechanisms by providing curated scholarly articles, detailed signaling pathway maps, and optimized laboratory protocols. This integrated ecosystem is designed to streamline your workflow from target identification to validation. By combining reagents of exceptional lot-to-lot consistency with expert knowledge resources, Creative Biolabs empowers scientists to dissect the complexities of specific tumor types with confidence, accelerating the journey from benchside discovery to clinical breakthrough.
Browse by Tumor Type
Loading...
Compare
